News Release
The Medicines Company to Participate in the Bank of America Merrill Lynch 2017 Health Care Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)--May 4, 2017-- The Medicines Company (NASDAQ:MDCO) today announced that it will participate in the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16, 2017, in Las Vegas, Nevada. Clive Meanwell, M.D., Ph.D., Chief Executive Officer, will participate in a fireside chat at 8:00 a.m., Pacific Daylight Time.

A live audio webcast will be available in the “Investors-Events/Presentations” section of The Medicines Company website. A replay of the fireside chat will be available for approximately 90 days.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.

Source: The Medicines Company

The Medicines Company
Media
Meg Langan, 973-290-6319
Vice President
margaret.langan@themedco.com
or
Investor Relations
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations
krishna.gorti@themedco.com